Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2009-01-22
2010-10-05
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C436S501000, C436S518000, C530S300000
Reexamination Certificate
active
07807386
ABSTRACT:
The aim of the present invention is to provide a non-intrusive way to isolate, concentrate and monitor the TSE disease-related pathogenic prion protein. The invention described several peptides and their ability to capture PrPScfrom brain homogenate of prion disease infected animal and human. These eight peptides do not capture cellular prion protein from individual with no prion disease.
REFERENCES:
patent: 7482172 (2009-01-01), Zheng
patent: 2002/0004586 (2002-01-01), Aguzzi
patent: WO/02/065133 (2002-08-01), None
Luo et al. Molecular modeling and deletion mutagenesis implicate the nuclear translocation sequence in structural integrity of fibroblast growth factor-1. J Biol Chem. 1996. 271(43): 26876-83.
Chon and Chaikof. Soluble heparin-binding peptides regulate chemokinesis and cell adhesive forces. Am J Physiol Cell Physiol. 280: C1394-C1402, 2001.
Horning Michelle
Lucas Zachariah
Ortho-Clinical Diagnostics, Inc.
LandOfFree
Peptides for discrimination of prions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for discrimination of prions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for discrimination of prions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4220627